{
    "Trade/Device Name(s)": [
        "UniCel DxC 800 SYNCHRON System Software Version 5.0"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K103842",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042291",
        "K060256"
    ],
    "Regulatory Class": "Class II, I",
    "Product Code(s)": [
        "CGA",
        "JE"
    ],
    "Summary Letter Date": "March 30, 2011",
    "Summary Letter Received Date": "March 31, 2011",
    "Submission Date": "December 29, 2010",
    "Regulation Number(s)": [
        "21CFR862.2160",
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Discrete photometric chemistry analyzer for clinical use",
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "UniCel DxC 800 SYNCHRON System"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric (discrete photometric) analysis"
    ],
    "Methodologies": [
        "Clinical chemistry analysis"
    ],
    "Submission Type(s)": [
        "Software",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter UniCel DxC 800 SYNCHRON System Software Version 5.0 as a clinical chemistry analyzer for in vitro diagnostic assays such as glucose determination",
    "Indications for Use Summary": "Intended for fully automated in vitro determination of cleared clinical laboratory assays such as glucose, including quantitative determination of glucose in serum, plasma, urine, or cerebrospinal fluid to aid in diagnosing and treating carbohydrate metabolism disorders.",
    "fda_folder": "Clinical Chemistry"
}